Background: Coexistence of temporomandibular joint discomfort along with cervical spine disorders is quite common, and is associated with many limitations and adverse symptoms for the patient. Both diagnostics and treatment of these ailments are difficult, and in many cases, the effects of therapy are not satisfactory. This study assessed the impact of a 3-week neck-only rehabilitation programme without direct intervention in the craniofacial area on the bioelectric activity of both the cervical spine and muscles in the craniofacial area among patients with idiopathic neck pain who do not report TMJ pain.

Design: A parallel group trial with follow-up; Setting: Rehabilitation Clinic.

Methods: Twenty five patients experiencing idiopathic neck pain underwent the 3-week rehabilitation programme. Thirty five age-matched subjects with no cervical spine and temporomandibular joint (TMJ) dysfunctions were control group. At baseline and after 3 weeks the cervical and craniofacial area muscles' bioelectrical activity (sEMG) was evaluated.

Results: In the experimental group during cervical flexion, a significant decrease of sEMG amplitude was noted in the right (mean 25.1 μV; 95% CI: 21.5-28.6 vs mean 16.8 μV; 95% CI: 13.8-19.7) and left (mean 25.9 μV; 95% CI: 21.7-30.0 vs mean 17.2 μV; 95% CI: 13.6-20.7) Sternocleidomastoid as well as a significant increase in sEMG amplitude of the right (mean 11.1 μV; 95% CI: 7.9-14.2 vs mean 15.7 μV; 95% CI: 12.1-19.2) and left (mean 15.3 μV; 95% CI: 11.9-18.6 vs mean 20.2 μV; 95% CI: 15.7-24.2) Upper Trapezius muscles. In the experimental group, after therapy right and left Sternocleidomastoid, Temporalis Anterior and Masseter muscles presented lower fatigue levels.

Conclusions: Three weeks of rehabilitation without any therapeutic intervention in temporomandibular joint significantly decreased the bioelectrical activity of the neck and craniofacial muscles while improving the muscle pattern of coactivation in participants with idiopathic neck pain who do not report temporomandibular joint pain. These observations could be helpful in the physiotherapeutic treatment of neck and craniofacial area dysfunctions.

Trial Registration: ID ISRCTN14511735-retrospectively registered.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075221PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0250746PLOS

Publication Analysis

Top Keywords

μv 95%
32
cervical spine
16
temporomandibular joint
16
craniofacial area
16
bioelectrical activity
12
idiopathic neck
12
neck pain
12
activity semg
8
rehabilitation programme
8
pain report
8

Similar Publications

Objectives: Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) face excess mortality compared with the general population. Mortality in clinical epidemiology research is often examined using death certificate diagnosis codes; however, the sensitivity of such codes in AAV is unknown.

Methods: We performed a retrospective cohort study using the Mass General Brigham AAV Cohort, including patients with AAV who died between 2002 and 2019.

View Article and Find Full Text PDF

Background: Heredity and epigenetics affect the pathogenesis of microscopic polyangiitis (MPA). Tyrosine kinase 2 (TYK2) polymorphisms (rs2304256C > A, rs280519A > G, and rs12720270G > A) may be potential protective factors against anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Current research suggests that TYK2 is associated with various autoimmune diseases; however, no study has examined the relationship between TYK2 polymorphisms and AAV.

View Article and Find Full Text PDF

Purification of AAV8 through a scalable two-step monolithic chromatography approach.

J Chromatogr A

January 2025

iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12 2780-901, Oeiras, Portugal; ITQB-NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal. Electronic address:

Adeno-associated viruses (AAV) are becoming increasingly popular as a powerful tool for gene delivery therapy applications. Although processes to produce AAV are established, future demand for this type of viral vector requires further development of manufacturing processes to make them more robust, scalable, and flexible to accommodate the rise of engineered capsids. This study focuses on designing and evaluating a two-step chromatography process for capturing and polishing AAV8 using monolith chromatography media.

View Article and Find Full Text PDF

Aims/hypothesis: Our aim was to assess sex differences in the efficacy of angiotensin receptor blockers (i.e. losartan and irbesartan) on kidney and cardiovascular outcomes in individuals with type 2 diabetes and diabetic kidney disease.

View Article and Find Full Text PDF

Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products.

Clin Pharmacol Ther

December 2024

Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.

Article Synopsis
  • Cell and gene therapies (CGTs) have shown potential for treating hard-to-treat conditions, but their development is risky for pharmaceutical companies due to uncertainties in clinical trials and regulatory approval.
  • An analysis of CGT products from 1993 to 2023 found that only 5.3% received regulatory approval, with higher chances for products with orphan designation and lower chances for oncology-related therapies.
  • Both CAR T cell therapies and AAV gene therapies showed a similar approval likelihood of 13.6%, highlighting that approval rates vary by product type and therapeutic indication.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!